Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Prioritizing comparative effectiveness research for cancer diagnostics using a regional stakeholder approach.

Klein G, Gold LS, Sullivan SD, Buist DS, Ramsey S, Kreizenbeck K, Snell K, Loggers ET, Gifford J, Watkins JB, Kessler L.

J Comp Eff Res. 2012 May;1(3):241-55.

2.

Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research.

Esmail LC, Roth J, Rangarao S, Carlson JJ, Thariani R, Ramsey SD, Veenstra DL, Deverka P.

Genet Med. 2013 Feb;15(2):115-22. doi: 10.1038/gim.2012.103. Epub 2012 Oct 4.

3.

Prioritization in comparative effectiveness research: the CANCERGEN Experience.

Thariani R, Wong W, Carlson JJ, Garrison L, Ramsey S, Deverka PA, Esmail L, Rangarao S, Hoban CJ, Baker LH, Veenstra DL; Center for Comparative Effectiveness Research in Cancer Genomics (CANCERGEN).

Med Care. 2012 May;50(5):388-93. doi: 10.1097/MLR.0b013e3182422a3b.

4.

Identification of topics for comparative effectiveness systematic reviews in the field of cancer imaging.

Rao M, Concannon TW, Iovin R, Yu WW, Chan JA, Lypas G, Terasawa T, Gaylor JM, Kong L, Rausch AC, Lau J, Kitsios GD.

J Comp Eff Res. 2013 Sep;2(5):483-95. doi: 10.2217/cer.13.61.

PMID:
24236745
5.

Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report.

Krishnan JA, Lindenauer PK, Au DH, Carson SS, Lee TA, McBurnie MA, Naureckas ET, Vollmer WM, Mularski RA; COPD Outcomes-based Network for Clinical Effectiveness and Research Translation.

Am J Respir Crit Care Med. 2013 Feb 1;187(3):320-6. doi: 10.1164/rccm.201206-0994WS. Epub 2012 Nov 15.

6.

What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.

Trosman JR, Weldon CB, Schink JC, Gradishar WJ, Benson AB 3rd.

J Comp Eff Res. 2013 Jul;2(4):461-77. doi: 10.2217/cer.13.42.

PMID:
24236686
7.

Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement.

Deverka PA, Lavallee DC, Desai PJ, Esmail LC, Ramsey SD, Veenstra DL, Tunis SR.

J Comp Eff Res. 2012 Mar;1(2):181-194.

8.

A tall order on a tight timeframe: stakeholder perspectives on comparative effectiveness research using electronic clinical data.

Holve E, Lopez MH, Scott L, Segal C.

J Comp Eff Res. 2012 Sep;1(5):441-51. doi: 10.2217/cer.12.47.

PMID:
24236421
9.

Stakeholder engagement for comparative effectiveness research in cancer care: experience of the DEcIDE Cancer Consortium.

Greenberg CC, Wind JK, Chang GJ, Chen RC, Schrag D.

J Comp Eff Res. 2013 Mar;2(2):117-25. doi: 10.2217/cer.12.80.

PMID:
24236554
10.

Evaluating Comparative Effectiveness Research Priorities for Care Coordination in Chronic Obstructive Pulmonary Disease: A Community-Based eDelphi Study.

Stellefson M, Alber J, Paige S, Castro D, Singh B.

JMIR Res Protoc. 2015 Aug 12;4(3):e103. doi: 10.2196/resprot.4591.

11.

Incorporating stakeholder perspectives in developing a translation table framework for comparative effectiveness research.

Gliklich RE, Leavy MB, Velentgas P, Dreyer NA, Tunis SR, Mohr P, Messner DA, Moloney RM, Karkare SU, Dubois RW, Graff JS.

J Comp Eff Res. 2012 May;1(3):281-92. doi: 10.2217/cer.12.25.

PMID:
24237409
12.

Engaging Stakeholders To Identify and Prioritize Future Research Needs [Internet].

O’Haire C, McPheeters M, Nakamoto E, LaBrant L, Most C, Lee K, Graham E, Cottrell E, Guise JM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jun.

14.

Patient and Stakeholder Engagement in the PCORI Pilot Projects: Description and Lessons Learned.

Forsythe LP, Ellis LE, Edmundson L, Sabharwal R, Rein A, Konopka K, Frank L.

J Gen Intern Med. 2016 Jan;31(1):13-21. doi: 10.1007/s11606-015-3450-z. Epub 2015 Jul 10.

15.

Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD.

Pickard AS, Lee TA, Solem CT, Joo MJ, Schumock GT, Krishnan JA.

Clin Pharmacol Ther. 2011 Dec;90(6):888-92. doi: 10.1038/clpt.2011.237. Epub 2011 Nov 2.

PMID:
22048220
16.

The ARRA investment in CER: a description of the midstream evaluation and how the funds were allocated and CER priorities addressed.

Esposito D, Yong PL, Rich E, Geonnotti K, Kimmey LD.

J Comp Eff Res. 2014 Nov;3(6):581-9. doi: 10.2217/cer.14.55.

PMID:
25494564
17.

Effective stakeholder participation in setting research priorities using a Global Evidence Mapping approach.

Clavisi O, Bragge P, Tavender E, Turner T, Gruen RL.

J Clin Epidemiol. 2013 May;66(5):496-502.e2. doi: 10.1016/j.jclinepi.2012.04.002. Epub 2012 Jul 18.

PMID:
22819249
19.

Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.

Facey K, Bradbury I, Laking G, Payne E.

Health Technol Assess. 2007 Oct;11(44):iii-iv, xi-267. Review.

20.

Future Research Needs for Diagnosis of Obstructive Sleep Apnea: Identification of Future Research Needs From Comparative Effectiveness Review No. 32 [Internet].

Balk EM, Chung M, Moorthy D, Chan JA, Patel K, Concannon TW, Ratichek SJ, Chang LKW.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Feb.

Supplemental Content

Support Center